Bismuth-based therapies for the first step eradication of Helicobacter pylori

Turkish Journal of Gastroenterology

Volumn 17, Issue 2, 2006, Pages 90-93

  Sezgin, Orhan ^a   Altintaş, Engin ^a   Üçbilek, Enver ^a   Tataroǧlu, Canten ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Bismuth; Eradication; Helicobacter pylori

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TETRACYCLINE; UREASE;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTACIDS; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; BISMUTH; BREATH TESTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; RANITIDINE; TETRACYCLINE; TREATMENT OUTCOME; UREASE; YOUNG ADULT;

EID: 34147108689     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Logan RPH, Walker MM. Epidemiology and diagnosis of Helicobacter pylori infection. BMJ 2001; 323: 920-2.
2. Sipponen P. Hyvarinen H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 1993; 28 (Suppl 196): 3-6.
3. Stolte M, Edit S. Healing gastric MALT lymphoma by eradication of H. pylori? Lancet 1993; 342: 568.
4. Akin L, Tezcan S, Hascelik G, Cakir B. Seroprevalence and some correlates of Helicobacter pylori at adult ages in Gulveren Health District, Ankara, Turkey. Epidemiol Infect 2004; 132: 847-56.
5. Özden A, Dumlu Ş, Dönderici Ö, et al. Helicobacter pylori infeksiyonunun ülkemizde seroepidemiyolojisi. Gastroenteroloji 1992; 3: 664-8.
6. Karaaslan H, Bektaş M, Soykan İ, et al. Türkiyede gönüllü kan donörlerinde Helicobacter pylori seroprevelansi. Turk J Gastroenterol 2003(Suppl); SB.03/1.
7. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-80.
8. Altintaş E, Sezgin O, Ulu O, et al. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pvlori. World J Gastroenterol 2004; 10: 1656-8.
9. Sivri B, Şimşek İ, Hülagu S, et al. Duodenal ülser iyileşmesi ve H. Pylori eradikasyonunda bir haftalik pantoprazol, amoksisilin ve klaritromisinden oluşan üclü tedavinin etkinliǧi, güvenilirliǧi ve tolere edilebilirliǧi. Turk J Gastroenterol 2003(Suppl); SB.07/1.
10. Uygun A, Yeşilova Z, Ateş Y, et al. Helicobacter pylori pozitif non-ülser dispepsili hastalarda Hp eradikasyon tedavisinde 14 ve 7 günlük lansoprazol, amoksisilin, klaritromisin tedavi protokollerinin karşilaştirilmasi. Turk J Gastroenterol 2004 (Suppl); PB.08/15.
11. Ertaş E, Tüzün A, Özden A. Helicobacter pylori pozitif fonksiyonel dispepside 7 ve 14 günlük pantoprazol, klaritromisin, amoksisilin kombinasyon tedavisinin eradikasyon etkinliǧinin ve eradikasyonun dispeptik semptomlar üzerine etkilerinin degerlendirilmesi. Turk J Gastroenterol 2004 (Suppl); PB.08/18.
12. Özer B, Coşar A, Serin E, et al. Helicobacter pylori tedavisinde bizmut içeren dörtlü tedavi rejimiyle düsük eradikasyon oranlari. Turk J Gastroenterol 2004 (Suppl); PB.08/39.
13. Gümürdülü Y, Serin E, Özer B, et al. Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. World J Gastroenterol 2004; 10: 668-71.
14. Güliter S, Keleş H, Özkurt ZN, et al. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of Helicobacter pylori? Turk J Gastroenterol 2005; 16: 29-33.
15. Avşar E, Kaymakoǧlu S, Erzin Y, et al. Dispeptik hastalarda Hp eradikasyonunda 14 günlük ranitidin bizmut sitrat bazli tedavi ile lansoprazol bazli üclü tedaviyi karşilaştiran çok merkezli, randomize, prospektif bir çalişma. Turk J Gastroenterol 2004 (Suppl); SB.10/1.
16. Önder GF, Aydin A, Doǧanavşargil B, et al. Hp infeksiyonunda pantoprazol, amoksisilin, klaritromisin kombinasyonu ile 1 ve 2 haftalik tedavilerin etkinliǧi. Turk J Gastroenterol 2003 (Suppl); PB.08/44.
17. Uygun A, Kadayifçi A, Yeşilova Z, et al. Hp eradikasyonunda lansoprazol ve pantoprazol içeren üclü rejimlerin etkinliǧinin karşilaştirilmasi. Turk J Gastroenterol 2003 (Suppl); PB.08/33.
18. Ünsal B, Ekinci N, Altinay A, et al. Helicobacter pylori'nin klirensinde üclü tedavinin etkinliǧi. Gastroenteroloji 1993; 4: 284-6.
19. Ataseven H, Mar N, Bahçecioǧlu HI, et al. Hp eradikasyonunda 14 günlük ranitidin bizmut sitrat, doksisiklin, amoksisilin ile pantoprazol, doksisiklin, amoksisilin tedavilerinin karşilaştirilmasi. Turk J Gastroenterol 2004 (Suppl); PB.08/57.
20. Gispert JP, Boixeda D, Martin C, et al. Helicobacter pylori and duodenal ulcer: a causal relation or mere association? Rev Clin Esp 1997; 197: 693-702.
21. Schwartz H, Krause R, Sahba B, et al. Triple versus dual therapy eradication of Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Am J Gastroenterol 1998; 93: 584-90.
22. Tursi A, Cammarato G, Montalto M, et al. Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 285-8.
23. Spinzi GC, Bierty L, Bortoli A, et al. Comparison of omeprazole and lansoprazole in short term triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998; 12: 433-8.
24. Labenz J, Stolte M, Peitz U, et al. One-week triple therapy with omeprazole, amoxycillin and clarithromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 207-10.
25. Biggard MA, Delchier JC, Riachi G, et al. One week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori infection in patients with non-ulcer dyspepsia: influence of dosage of amoxycillin and clarithromycin. Aliment Pharmacol Ther 1998; 12: 383-8.
26. Sezgin O, Asian G, Altintaş. E, et al. Mersin'de mide biyopsi örneklerindeki helicobacter pylori'nin 23S rRNA'sinda nokta mutasyonu ve klaritromisin direncinin PCR-RFLP analizi ile gösterilmesi: Ön sonuçlar. Turk J Gastroenterol 2005 (Suppl); PB.01/9.
27. Yahnay Çirak M, Ünal S, Türet S, et al. H. pylori infeksiyonunda klaritromisin direncinin Real-Time PCR teknigi ile genetik olarak belirlenmesi. Turk J Gastroenterol 2004 (Suppl); PB.08/30.
28. Ozden A, Bozdayi G, Baglan P, et al. Helicobacter pylori'nin klaritromisine karşi direncinin sikliǧi. Turk J Gastroenterol 2004 (Suppl); SB.07/6.
29. Işiksal F, Colakoglu S, Köksal F, et al. Helicobacter pylori-antibiyotik direnci. Turk J Gastroenterol 2003 (Suppl); SB.07/5.
30. Dore MP, Graham DY, Mele R, et al. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. Am J Gastroenterol 2002; 97: 857-60.
31. Vakil N, Cutler A. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori. Am J Gastroenterol 1999; 94: 1197-9.
32. Uygun A, Yeşilova Z, Ateş Y, et al. Hp pozitif non-ülser dispepsili hastalarda 1. basamakta ranitidin bizmut sitrat'li 3 farkli tedavi rejiminin karşilaştirilmasi. Turk J Gastroenterol 2005 (Suppl); SB.01/11.